The hierarchical process of differentiation of long-lived antibody-secreting cells is dependent on integrated signals derived from antigen and IL-17A

PLoS One. 2013 Sep 18;8(9):e74566. doi: 10.1371/journal.pone.0074566. eCollection 2013.

Abstract

Switched CD19-positive memory B cells purified from mice with chronic immune response against Thalassophrynenattereri venom proteins were cultured with venom or cytokines. Our results confirm the existence of a hierarchic process of differentiation: activated memory B cells progressively acquire increasing levels of CD138 and decreasing levels of CD45R/B220 to finally arrive at ASC with B220(neg) phenotype, which are IgG1-secreting cells. Only Bmem from peritoneal cavity or bone marrow of VTn immunized mice presented the capacity to generate ASC functionally active. IL-17A or IL-21/IL-23/IL-33 improves the ability of venom to induce intracellular IgG of peritoneal derived-ASC. Cognate stimulation with venom and IL-17A is sufficient to down-regulate the expression of CD45R/B220. BAFF-R is up-regulated in splenic or medullar derived-ASC stimulated by venom, CpG or cytokines. Only splenic derived-ASC up-regulate Bcl-2 expression after CpG or the combination of IL-21/IL-23/IL-33 stimulation. Finally, the activation of ASC for IgG1 secretion is triggered by venom proteins in peritoneal cavity and by IL-17A in medullar niche. These results show the importance of the integration of signals downstream of BCR and IL17-A receptors in modulating ASC differentiation, focusing in the microenvironment niche of their generation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibody-Producing Cells / cytology*
  • Antibody-Producing Cells / drug effects
  • Antibody-Producing Cells / metabolism
  • Antigens / immunology*
  • Antigens, CD19 / metabolism
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • B-Cell Activation Factor Receptor / metabolism
  • B-Lymphocytes / immunology
  • Cell Differentiation / drug effects
  • Cell Differentiation / immunology*
  • Cell Membrane / metabolism
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Fish Venoms / immunology
  • Immunoglobulin G / biosynthesis
  • Immunologic Memory / drug effects
  • Interleukin-17 / metabolism*
  • Interleukin-23 / pharmacology
  • Interleukins / pharmacology
  • Leukocyte Common Antigens / metabolism
  • Lymphocyte Count
  • Male
  • Mice
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Recombinant Proteins / pharmacology
  • Signal Transduction* / drug effects
  • Signal Transduction* / immunology
  • Spleen / cytology
  • Toll-Like Receptor 9 / metabolism

Substances

  • Antigens
  • Antigens, CD19
  • B-Cell Activation Factor Receptor
  • Fish Venoms
  • Immunoglobulin G
  • Interleukin-17
  • Interleukin-23
  • Interleukins
  • Proto-Oncogene Proteins c-bcl-2
  • Recombinant Proteins
  • Tlr9 protein, mouse
  • Toll-Like Receptor 9
  • Leukocyte Common Antigens
  • interleukin-21

Grants and funding

This work was supported by FAPESP 2012/50001-0 and 2009/53078-1 CNPQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.